OT
Ovid Therapeutics Inc
🇩🇪XFRA.1OTGermanyHealthcare
€2.30EURdown -0.06 (-2.54%)OpenEnd of day5:13 PM
Price€2.30-0.06 (-2.54%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US6904691010
- CUSIP
- Not reported
Company
- Employees
- 23
- Headquarters
- New York, United States
- Website
- https://www.ovidrx.com
- CEO
- Ms. Margaret Alexander
Market
- Shares outstanding
- 195.3M
- Market cap
- €449.19M
Key dates
- Next earnings
- Nov 11, 2026
Highlights
- Market cap
- €449.19M
- EPS LTM
- -$0.18calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.58M-76.2%down year on year
- Net income
- -$34.49M+9.65%up year on year
- Gross margin
- 92.92%+1.34%up year on year
- Free cash flow
- -$54.77M-36.64%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.